G Gardani - Concepedia

Author

G Gardani

Also Known As

Fondazione IRCCS Istituto Nazionale Tumori, Italy, G Gardani, G S Gardani, G Viganotti, G. Gardani, G.S. Gardani, GianStefano Gardani, Gianstefano Gardani, Maura Faraci

102

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Azienda Ospedaliera San Gerardo University of Milano-Bicocca University of Milan Fondazione IRCCS Istituto Nazionale dei Tumori Centre Georges François Leclerc

About

G Gardani is an author at Azienda Ospedaliera San Gerardo specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	24	1.7K
2	Health Sciences	13	13	1.2K
3	Immunology	3	3	151
4	Endocrinology	1	1	15
5	Obstetrics	1	1	49

G Gardani

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy Jean-Claude Horiot, R. Le Fur, T. Nguyen, Radiotherapy and Oncology Neuro-oncologySurgical OncologyConventional FractionationRadiation TherapyMedicine	1992	682
Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study Adriano Paccagnella, Maria Grazia Ghi, L. Loreggian, Annals of Oncology Advanced HeadNeuro-oncologyPhase IiRadiation TherapyHealth Sciences	2009	185
Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1. Paolo Lissoni, Fabio Malugani, Andrés Cadena Bonfanti, PubMed ImmunologyImmunoeditingPathologyVegf Blood ConcentrationsTumor Biology	2002	101
Efficacy of Cancer Chemotherapy in Relation to the Pretreatment Number of Lymphocytes in Patients with Metastatic Solid Tumors Paolo Lissoni, F Brivio, Luca Fumagalli, The International Journal of Biological Markers	2004	101
Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations. Giulio Cerea, Massimo Vaghi, A Ardizzoia, PubMed Tumor BiologyChemoprevention StrategyRandomized StudyMedicineCpt-11 Therapeutic Activity	2003	96
Effect of bicalutamide therapy on prolactin response to L-dopa in metastatic prostate cancer patients. Paolo Lissoni, Fabio Malugani, Marilena Casu, PubMed	2002	87
Hyperfractionated compared with conventional radiotherapy in oropharyngeal carcinoma: an EORTC randomized trial Jean-Claude Horiot, R. Le Fur, T. Nguyen, European Journal of Cancer and Clinical Oncology Neuro-oncologyRadiation MedicineRadiation TherapyMedicineOropharyngeal Carcinoma	1990	65
Response to neoadjuvant therapy in locally advanced rectal cancer: assessment with diffusion-weighted MR imaging and 18FDG PET/CT Davide Ippolito, Letizia Monguzzi, Luca Guerra, Abdominal Imaging Positron Emission TomographyOncologic ImagingMedical ImagingNeoadjuvant TherapyMedicine	2012	60
Radiotherapy-induced lymphocytopenia: changes in total lymphocyte count and in lymphocyte subpopulations under pelvic irradiation in gynecologic neoplasms. Paolo Lissoni, Sofia Meregalli, E. Bonetto, PubMed Lymphoid NeoplasiaTotal Lymphocyte CountRadiation TherapyMedicineGynecology	2006	49
Quality indicators in radiotherapy L. Cionini, G Gardani, P. Gabriele, Radiotherapy and Oncology ReliabilityAdaptive RadiotherapyQuality IndicatorsRadiation TherapyMedicine	2007	48

Page 1